ES2095884T3 - Agente antiviral. - Google Patents

Agente antiviral.

Info

Publication number
ES2095884T3
ES2095884T3 ES91109964T ES91109964T ES2095884T3 ES 2095884 T3 ES2095884 T3 ES 2095884T3 ES 91109964 T ES91109964 T ES 91109964T ES 91109964 T ES91109964 T ES 91109964T ES 2095884 T3 ES2095884 T3 ES 2095884T3
Authority
ES
Spain
Prior art keywords
antiviral agent
polysaccharide
chem
integer
active component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91109964T
Other languages
English (en)
Inventor
Katsushi Hagiwara
Mikio Kikuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taito Co Ltd
Original Assignee
Taito Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taito Co Ltd filed Critical Taito Co Ltd
Application granted granted Critical
Publication of ES2095884T3 publication Critical patent/ES2095884T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UN AGENTE ANTI-VIRUS ORAL QUE CONTIENE UN POLISACARIDO CON LA SIGUIENTE ESTRUCTURA QUIMICA COMO COMPONENTE ACTIVO, (DONDE N ES UN NUMERO ENTERO DE AL MENOS 16).
ES91109964T 1990-06-25 1991-06-18 Agente antiviral. Expired - Lifetime ES2095884T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2166251A JP2911554B2 (ja) 1990-06-25 1990-06-25 抗ウィルス剤

Publications (1)

Publication Number Publication Date
ES2095884T3 true ES2095884T3 (es) 1997-03-01

Family

ID=15827923

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91109964T Expired - Lifetime ES2095884T3 (es) 1990-06-25 1991-06-18 Agente antiviral.

Country Status (11)

Country Link
US (1) US5320849A (es)
EP (1) EP0463540B1 (es)
JP (1) JP2911554B2 (es)
AT (1) ATE144426T1 (es)
AU (1) AU642023B2 (es)
CA (1) CA2045212C (es)
DE (1) DE69122805T2 (es)
DK (1) DK0463540T3 (es)
ES (1) ES2095884T3 (es)
GR (1) GR3022165T3 (es)
NZ (1) NZ238673A (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
EP0490995A1 (en) * 1989-09-08 1992-06-24 Alpha Beta Technology Method for producing soluble glucans
US5811542A (en) * 1989-09-08 1998-09-22 Alpha-Beta Technology, Inc. Method for producing soluble glucans
US5488040A (en) * 1989-09-08 1996-01-30 Alpha-Beta Technology, Inc. Use of neutral soluble glucan preparations to stimulate platelet production
GB9714102D0 (en) * 1997-07-04 1997-09-10 Ciba Geigy Ag Compounds
US6046323A (en) * 1997-07-29 2000-04-04 The Collaborative Group, Ltd. Conformations of PPG-glucan
JPH11313667A (ja) * 1998-03-24 1999-11-16 Pacific Corp β―１，６―分枝―β―１，３―グルカンを分離するためのスエヒロタケの液体培養方法及びこの方法により製造されたβ―１，６―分枝―β―１，３―グルカンを含有する外用剤組成物
US6369216B1 (en) 1998-09-25 2002-04-09 Biopolymer Engineering Pharmaceutical, Inc. Very high molecular weight β-glucans
AU6261999A (en) 1998-09-25 2000-04-17 Collaborative Group, Ltd., The Very high molecular weight beta-glucans
US7507724B2 (en) 2001-01-16 2009-03-24 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
US7906492B2 (en) 2001-01-16 2011-03-15 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
US7914799B2 (en) * 2001-08-27 2011-03-29 Immunitor USA, Inc. Anti-fungal composition
US6716448B2 (en) 2001-10-05 2004-04-06 Rubicon Scientific Llc Domesticated household pet food including maintenance amounts of ivermectin
US7052712B2 (en) * 2001-10-05 2006-05-30 Rubicon Scientific Llc Animal feeds including actives and methods of preparing same
US6866862B2 (en) * 2001-10-05 2005-03-15 Rubicon Scientific Animal feeds including heartworm-prevention drugs
WO2004014320A2 (en) * 2002-08-13 2004-02-19 Biopolymer Engineering, Inc. Methods of using beta glucan as a radioprotective agent
US20060165700A1 (en) * 2002-09-04 2006-07-27 Ostroff Gary R Cancer therapy using whole glucan particles and antibodies
CA2496508C (en) 2002-09-04 2014-04-22 University Of Louisville Research Foundation, Inc. Cancer therapy using beta glucan and antibodies
US20040091579A1 (en) * 2002-11-13 2004-05-13 Rubicon Scientific Llc; Extruded foodstuffs having maintenance level actives
KR100419191B1 (ko) * 2003-06-23 2004-02-19 주식회사 엔바이오테크놀러지 독감 인플루엔자 바이러스 및 전염성 위장염 코로나바이러스 억제 활성을 갖는 효모변이주 아이에스2 유래수용성 글루칸 올리고머를 함유하는 조성물
US7197521B2 (en) * 2003-11-21 2007-03-27 Intel Corporation Method and system performing concurrently mark-sweep garbage collection invoking garbage collection thread to track and mark live objects in heap block using bit vector
US8323644B2 (en) 2006-01-17 2012-12-04 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
WO2013171137A1 (en) 2012-05-16 2013-11-21 Wintershall Holding GmbH Method for precipitating and re-dissolving beta-glucan
WO2014006088A1 (en) 2012-07-04 2014-01-09 Wintershall Holding GmbH Genetically modified microorganisms capable of producing beta-glucans and methods for producing beta-glucans
US20180273647A1 (en) 2014-10-31 2018-09-27 Wintershall Holding GmbH Method for concentrating beta-glucans
WO2016087521A1 (en) 2014-12-04 2016-06-09 Wintershall Holding GmbH Method for preparing an aqueous solution of beta-glucan
EP3230464B1 (en) 2014-12-12 2018-09-19 Wintershall Holding GmbH Process for the fermentation of fungal strains
CA3000556A1 (en) 2015-10-02 2017-04-06 Wintershall Holding GmbH Redispersion of schizophyllan

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3943247A (en) * 1972-05-22 1976-03-09 Kaken Kagaku Kabushiki Kaisha Treatment of bacterial infections with glucan compositions
JPS5919121B2 (ja) * 1975-10-31 1984-05-02 タイトウ カブシキガイシヤ シンキノヤクリカツセイタトウブンカイブツノ セイゾウホウホウ
SE445013B (sv) * 1979-06-21 1986-05-26 Landstingens Inkopscentral Medel for att forebygga eller behandla infektioner hos menniskor och djur
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
JP2681653B2 (ja) * 1988-05-13 1997-11-26 台糖株式会社 抗エイズウィルス剤
FR2631829B1 (fr) * 1988-05-30 1992-04-03 Pasteur Institut Exopolysaccharides fongiques ayant une activite immunostimulante, leur procede d'obtention et composition therapeutique les contenant
JP2771178B2 (ja) * 1988-07-06 1998-07-02 日本電気アイシーマイコンシステム株式会社 除算回路
CA1330303C (en) * 1989-02-20 1994-06-21 Libor Henry Nikl Composition and process to enhance the efficacy of a fish vaccine
JPH062676B2 (ja) * 1989-02-20 1994-01-12 台糖株式会社 水溶性グルカンからなる魚病の予防剤

Also Published As

Publication number Publication date
US5320849A (en) 1994-06-14
EP0463540A1 (en) 1992-01-02
GR3022165T3 (en) 1997-03-31
ATE144426T1 (de) 1996-11-15
AU642023B2 (en) 1993-10-07
CA2045212C (en) 1998-01-20
JPH0454124A (ja) 1992-02-21
AU7928991A (en) 1992-01-02
DE69122805T2 (de) 1997-04-03
CA2045212A1 (en) 1991-12-26
DE69122805D1 (de) 1996-11-28
JP2911554B2 (ja) 1999-06-23
DK0463540T3 (da) 1996-11-18
EP0463540B1 (en) 1996-10-23
NZ238673A (en) 1992-07-28

Similar Documents

Publication Publication Date Title
DE69122805D1 (de) Antivirusmittel
IL89921A0 (en) 1,3-dioxolane derivatives and pharmaceutical compositions containing the same
ES2175860T3 (es) Procedimiento quimico.
EP1087960A4 (en) MACROCYCLIC ANALOGUES AND METHOD FOR THEIR USE AND MANUFACTURE
FI921087A0 (fi) Nya estrar av tienylkarboxylsyror och aminoalkoholer, deras kvaterniseringsprodukter och framstaellning och anvaendning av naemnda foereningar.
MD1224C2 (ro) Utilizare a analogilor nucleozidici cu 1,3-oxatiolan în tratamentul hepatitei B
IL96882A0 (en) Uracil derivatives and pesticides containing the same as active ingredient
MX9203032A (es) Una solucion farmaceutica.
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
DE3688150D1 (de) Antikrebs-chinazolinon-derivate.
DE69331721D1 (de) Neue carbamazepin hapten Analoge
KR870008824A (ko) 디플루오로할로메톡시페닐 유도체 및 그것을 유효성분으로 함유하는 살비제(殺碑制)
ES2126636T3 (es) Derivados del bencimidazol con actividad antidiabetica y antiagregante plaquetaria.
FI885454A0 (fi) Administrationssystem, som laongsamt frigoer substituerade dihydropyridiner.
CA2007771A1 (en) Ocular lens material
ATE86860T1 (de) Praeparat gegen ulcus.
ATE86259T1 (de) Antibakterielle 9-deoxy-9a-allyl und propargyl-9a-aza-9a-homoerythromycin-a-derivate
EP0646625A3 (en) Fluorine-containing copolymer composition.
AU621996B2 (en) 2,5,6,7-tetranor-4,8-inter-m-phenylene pgi2 derivatives
DK0413145T3 (da) Radioaktivt diagnotisk middel
AU566243B2 (en) Optically active imidazolylpropanols
DE3783937D1 (de) 1,4-naphthochinonderivate enthaltende rodentizide zusammensetzungen.
KR910000645A (ko) 개선된 경련치료제
RO94553A (ro) Compozitie insecticida
ATE163005T1 (de) Saintopin derivate

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 463540

Country of ref document: ES